相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100
Bryan P. Schneider et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer:: A randomized phase III study
Leonard B. Saltz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
Rafael G. Amado et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Steven J. Harper et al.
NATURE REVIEWS CANCER (2008)
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Kathy Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Phase I evaluation of CDP791, a PEGylated di-Fab' conjugate that binds vascular endothelial growth factor receptor 2
N. C. Ton et al.
CLINICAL CANCER RESEARCH (2007)
VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade
John S. Rudge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Anti-PIGF inhibits growth of VEGF(R)-Inhibitor-Resistant tumors without affecting healthy vessels
Christian Fischer et al.
CELL (2007)
Vascular endothelial growth factor trap in non-small cell lung cancer
GregoryJ. Riely et al.
CLINICAL CANCER RESEARCH (2007)
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200
Bruce J. Giantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
VEGF trap in combination with radiotherapy improves tumor control in U87 glioblastoma
Phyllis R. Wachsberger et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies
Hans-Peter Gerber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Targeting tumorangiogenesis in lung cancer by suppression of VEGF and its receptor - Results from clinical trials and novel experimental approaches
H. Kuhn et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
George D. Demetri et al.
LANCET (2006)
Clinical significance of vascular endothelial growth factor - a expression in Ewing's sarcoma
Michael Kreuter et al.
EUROPEAN JOURNAL OF CANCER (2006)
Vascular endothelial growth factor trap combined with paclitaxel strikingly inhibits tumor and ascites, prolonging survival in a human ovarian cancer model
LM Hu et al.
CLINICAL CANCER RESEARCH (2005)
The prognostic significance of vascular endothelial growth factor levees in sera of non-small cell lung cancer patients
A Kaya et al.
RESPIRATORY MEDICINE (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines
M Fukasawa et al.
CLINICAL CANCER RESEARCH (2004)
Vascular endothelial growth factor as a target for anticancer therapy
N Ferrara
ONCOLOGIST (2004)
Regression of established tumors and metastases by potent vascular endothelial growth factor blockade
JZ Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
VEGF-Trap: A VEGF blocker with potent antitumor effects
J Holash et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/neu protein and vascular endothelial growth factor
MD Pegram et al.
SEMINARS IN ONCOLOGY (2002)
Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications
M Toi et al.
LANCET ONCOLOGY (2001)
Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies
AF List
ONCOLOGIST (2001)
Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients
JC Lee et al.
EUROPEAN JOURNAL OF CANCER (2000)
分享论文
